Despite magnetic resonance imaging (MRI) being a mainstay in the oncologic care for many
disease sites, it has not routinely been used in early lung cancer diagnosis, staging, and …

Radiotherapy remains the cornerstone of curative treatment for inoperable locally advanced
lung cancer, given concomitantly with platinum-based chemotherapy. With poor overall …

Simple Summary Magnetic resonance (MR) imaging had limited clinical indications in
patients with thoracic malignancies in the last a few decades. However, technical advances …

MRI has superior soft-tissue definition compared with existing imaging modalities in
radiation oncology; this has the added benefit of functional as well as anatomical imaging …

Since the publication of the Radiologic Diagnostic Oncology Group Report in 1991, the
clinical application of pulmonary magnetic resonance imaging (MRI) in patients with lung …

Since the clinical introduction of magnetic resonance imaging (MRI), the chest has been one
of its most challenging applications, and since the 1980s many physicists and radiologists …

Since MR imaging was introduced for the assessment of thoracic and lung diseases, various
limitations, mostly related to the relatively low proton density of lung parenchyma, the …

Lung cancer is the leading cause of cancer death worldwide. Prognosis and treatment
outcomes are known to be related to the disease stage at the time of diagnosis. Therefore …

Magnetic resonance imaging (MRI) of the lung has shown tremendous progress in recent
years. This includes parallel imaging, new contrast agents and mechanisms, ultrafast …

Tumor, lymph node, and metastasis (TNM) classification of lung cancer is typically
performed with the TNM staging system, as recommended by the Union Internationale …